Polymorphism in the microglial receptor CD33 gene has been linked to late-onset Alzheimer disease (AD), and reduced expression of the CD33 sialic acid-binding domain confers protection. Here, CD33 is linked to early-onset autosomal dominant Alzheimer disease.